SQUARE has invested in state of the art formulation plants aligned to regulated market standards. Six manufacturing units of the Dhaka site can produce pharmaceutical products maintaining cGMP requirement for highly regulated markets in Europe, Australia and USA. Other five manufacturing units at Pabna site are producing finished formulations targeting markets in ASEAN, SAARC and marketing in RoW region. We have 700 product approvals for export markets and 900 product approvals for Bangladesh market.
SQUARE Pharmaceuticals Ltd. is already supplying products to the following markets:
Asia: Afghanistan, Azerbaijan, Bhutan, Cambodia, Georgia, Hong Kong, Iraq, Laos, Macau, Malaysia, Maldives, Myanmar, Nepal, Philippines, Singapore, Sri Lanka, Tajikistan, Vietnam, Yemen.
Africa: Cameroon, Eritrea, Ivory Coast, Kenya, Libya, Mauritania, Mauritius, Mozambique, Nigeria, Somalia, Sudan, Tanzania, Uganda.
Oceania: Fiji, Palau, Papua New Guinea.
Central & South America: Belize, Costa Rica, Jamaica, Nicaragua, Panama, Suriname.
Europe: UK(Contract Manufacturing)
Hongkong, Canada, Uganda, Cambodia, Fiji, Vietnam.
UK-MHRA and TGA-Australia
International Marketing Department
Square Pharmaceuticals Ltd.
48, Mohakhali Commercial Area
Dhaka 1212. Bangladesh
Telephone: +880 2 9859007
Fax: +880 2 8834941
SQUARE Herbal & Nutraceuticals Ltd. (SHNL)